118 related articles for article (PubMed ID: 30615324)
1. [The laboratory evaluation of dynamics of progression of liver fibrosis under chronic hepatitis].
Schekotova AP; Bulatova IA; Schekotov VV; Titov VN
Klin Lab Diagn; 2016 Oct; 61(10):686-9. PubMed ID: 30615324
[TBL] [Abstract][Full Text] [Related]
2. [The noninvasive evaluation of degree of expression of fibrosis of liver and significance of polymorphism of gene of hyaluronic acid under chronic hepatitis C].
Bulatova IA; Schekotova AP; Krivtsov AV; Schekotov VV; Pavlov AI
Klin Lab Diagn; 2015 Mar; 60(3):18-21. PubMed ID: 26031159
[TBL] [Abstract][Full Text] [Related]
3. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
Attallah AM; Omran D; Omran MM; Albannan MS; Zayed RA; Saif S; Farid A; Hassany M; Yosry A
Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
[TBL] [Abstract][Full Text] [Related]
4. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection.
Metwally MA; Zein CO; Zein NN
Am J Gastroenterol; 2004 Feb; 99(2):286-91. PubMed ID: 15046219
[TBL] [Abstract][Full Text] [Related]
6. Iron, hepatic stellate cells and fibrosis in chronic hepatitis C.
Rigamonti C; Andorno S; Maduli E; Morelli S; Pittau S; Nicosia G; Boldorini R; Sartori M
Eur J Clin Invest; 2002 Mar; 32 Suppl 1():28-35. PubMed ID: 11886429
[TBL] [Abstract][Full Text] [Related]
7. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group.
McHutchison JG; Blatt LM; de Medina M; Craig JR; Conrad A; Schiff ER; Tong MJ
J Gastroenterol Hepatol; 2000 Aug; 15(8):945-51. PubMed ID: 11022838
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease.
Testa E; Malfatti F; Milazzo S; Cordiviola C; Cotellessa T; Marabotto E; Giannini E; Ceppa P; Mamone M; Risso D; Testa R
Liver Int; 2006 May; 26(4):439-44. PubMed ID: 16629647
[TBL] [Abstract][Full Text] [Related]
9. Alpha-2-macroglobulin and hyaluronic acid as fibromarkers in patients with chronic hepatitis C.
Pitekova B; Kupcova V; Uhlikova E; Mojto V; Turecky L
Bratisl Lek Listy; 2017; 118(11):658-661. PubMed ID: 29216721
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum α-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story.
Abdel-Razik A; Mousa N; Abdel-Aziz M; Elhelaly R; Elzehery R; Zalata K; Elkashef W; Fouda O; Awad M; Hafez M; Eldars W
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):313-22. PubMed ID: 26618566
[TBL] [Abstract][Full Text] [Related]
11. Gender and liver fibrosis in chronic hepatitis: the role of iron status.
Rigamonti C; Andorno S; Maduli E; Capelli F; Boldorini R; Sartori M
Aliment Pharmacol Ther; 2005 Jun; 21(12):1445-51. PubMed ID: 15948811
[TBL] [Abstract][Full Text] [Related]
12. Role of hyaluronic acid, its degrading enzymes, degradation products, and ferritin in the assessment of fibrosis stage in Egyptian patients with chronic hepatitis C.
El-mezayen HA; Toson el-SA; Shiha GE
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):69-76. PubMed ID: 23011038
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
Chen CH; Lin ST; Kuo CL; Nien CK
Hepatogastroenterology; 2008; 55(85):1423-7. PubMed ID: 18795704
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of liver fibrosis in patients with thalassemia: the important role of hyaluronic acid.
Papastamataki M; Delaporta P; Premetis E; Kattamis A; Ladis V; Papassotiriou I
Blood Cells Mol Dis; 2010 Oct; 45(3):215-8. PubMed ID: 20605573
[TBL] [Abstract][Full Text] [Related]
15. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
[TBL] [Abstract][Full Text] [Related]
16. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
[TBL] [Abstract][Full Text] [Related]
17. Value of reelin for assessing hepatic fibrogenesis in a group of Egyptian HCV infected patients.
Mansy SS; Nosseir MM; Zoheiry MA; Hassanein MH; Guda MF; Othman MM; AbuTalab H
Clin Chem Lab Med; 2014 Sep; 52(9):1319-28. PubMed ID: 24803609
[TBL] [Abstract][Full Text] [Related]
18. α-fetoprotein levels after interferon therapy predict regression of liver fibrosis in patients with sustained virological response.
Tachi Y; Hirai T; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H
J Gastroenterol Hepatol; 2016 May; 31(5):1001-8. PubMed ID: 27123974
[TBL] [Abstract][Full Text] [Related]
19. Iron and proinflammatory cytokines in chronic hepatitis C virus infection.
López-Prieto J; González-Reimers E; Alemán-Valls MR; de la Vega-Prieto MJ; Abreu-González P; Pelazas-González R; Hernández-Luis R; Jorge-Ripper C; Santolaria-Fernández F
Biol Trace Elem Res; 2013 Oct; 155(1):5-10. PubMed ID: 23892696
[TBL] [Abstract][Full Text] [Related]
20. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.
Crawford DH; Murphy TL; Ramm LE; Fletcher LM; Clouston AD; Anderson GJ; Subramaniam VN; Powell LW; Ramm GA
Hepatology; 2009 Feb; 49(2):418-25. PubMed ID: 19177571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
